Imaging News

Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.

The retinal image-based, deep-learning cardiac BioAge model accurately stratified individuals by traditional cardiovascular disease risk biomarkers, with leukocyte telomere length inversely related to BioAge score, researchers reported.

Nanox announced its subsidiary, Nanox.AI, received FDA 510(k) clearance for its AI-powered coronary artery disease detection solution.

AISAP announced the FDA granted 510(k) clearance for its first-in-class, AI-powered point-of-care ultrasound software platform for the measurement of several cardiac pathologies.

The Care of the Athletic Heart Conference, held at Heart House in Washington, D.C., in early June, covered the entire scope of sports cardiology, with sessions tailored to new and seasoned sports cardiologists.

High-quality CT and stress testing should be able to effectively and safely diagnose patients with stable chest pain and suspected CAD, regardless of BMI, while improving clinical efficiency, researchers reported.

With the use of AI-enabled quantitative coronary plaque analysis, researchers developed nomograms designed to improve risk stratification of patients who may be at risk for atherosclerosis.

Explanations of echocardiography findings written using ChatGPT may be suitable to educate patients about their health status and reduce physician workload, according to data published in JACC: Cardiovascular Imaging.

Elevated lipoprotein(a), despite a coronary artery calcium score of 0, could portend coronary plaque burden and may be a potential marker for early atherosclerosis intervention, researchers reported.